Cumulative D-Index Predicts the Duration of Febrile Neutropenia in AML Patients

被引：0
|
作者：
Kubo, Hiroyuki [1 ]
Imataki, Osamu [1 ]
Uchida, Shumpei [1 ]
Yokokura, Shigeyuki [1 ]
Uemura, Makiko [1 ]
Kadowaki, Norimitsu [2 ]
机构：
[1] Kagawa Univ, Kagawa, Japan
[2] Kagawa Univ, Div Hematol Rheumatol & Resp Med, Dept Intern Med, Kagawa, Japan
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.5180.5180
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5180
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Procalcitonin Guiding Antimicrobial Therapy Duration in Febrile Cancer Patients with Documented Infection or Neutropenia
    El Haddad, Hanine
    Chaftari, Anne-Marie
    Hachem, Ray
    Micheal, Majd
    Jiang, Ying
    Yousif, Ammar
    Raad, Sammy
    Jordan, Mary
    Chaftari, Patrick
    Raad, Issam
    SCIENTIFIC REPORTS, 2018, 8
  • [22] Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study
    Carmona-Bayonas, Alberto
    Jimenez-Fonseca, Paula
    Virizuela Echaburu, Juan
    Antonio, Maite
    Font, Carme
    Biosca, Merce
    Ramchandani, Avinash
    Martinez, Jeronimo
    Hernando Cubero, Jorge
    Espinosa, Javier
    Martinez de Castro, Eva
    Ghanem, Ismael
    Beato, Carmen
    Blasco, Ana
    Garrido, Marcelo
    Bonilla, Yaiza
    Mondejar, Rebeca
    Arcusa Lanza, Maria Angeles
    Aragon Manrique, Isabel
    Manzano, Aranzazu
    Sevillano, Elena
    Castanon, Eduardo
    Cardona, Merce
    Gallardo Martin, Elena
    Perez Armillas, Quionia
    Sanchez Lasheras, Fernando
    Ayala de la Pena, Francisco
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (05) : 465 - U124
  • [23] 3D index calculated from duration and severity of neutropenia and a degree of fever as prognostic factors predicting mortality of chemotherapy-induced febrile neutropenia in hematologic malignancies
    Shirasaki, Ryosuke
    Akiyama, Nobu
    Tashiro, Haruko
    Matsuo, Takuji
    Yamamoto, Tadashi
    Oka, Yoko
    Kawasugi, Kazuo
    Shirafuji, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma
    Muñoz, L
    Martino, R
    Subirà, M
    Brunet, S
    Sureda, A
    Sierra, J
    LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) : 585 - 589
  • [25] c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia
    Kubo, Hiroyuki
    Imataki, Osamu
    Kubo, Yukiko Hamasaki
    Uemura, Makiko
    Kadowaki, Norimitsu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (05) : 590 - 595
  • [26] c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia
    Hiroyuki Kubo
    Osamu Imataki
    Yukiko Hamasaki Kubo
    Makiko Uemura
    Norimitsu Kadowaki
    International Journal of Clinical Oncology, 2019, 24 : 590 - 595
  • [27] Cumulative discontinuous neutropenia predicts risk of invasive Aspergillosis both during and after resolution of neutropenia in patients with hematologic malignancy
    Walker, R. C.
    Issa, N.
    Hoskin, T. L.
    St Sauver, J. L.
    Schleck, C. D.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 : S72 - S72
  • [28] Predictors of development of pneumonia during chemotherapy induced febrile neutropenia in patients with acute myelogenous leukemia (AML).
    Burney, IA
    Favis, G
    Sorathia, A
    Siddiqui, T
    BLOOD, 1997, 90 (10) : 3809 - 3809
  • [29] BODY MASS INDEX FOR SCREENING BACTEREMIA AMONG PEDIATRIC CANCER PATIENTS WITH FEBRILE NEUTROPENIA
    Ojha, R.
    Aviles-Robles, M.
    Johnson, K. M.
    Phillips, B.
    Caniza, M. A.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S398 - S398
  • [30] IL-8 Predicts Pediatric Oncology Patients With Febrile Neutropenia at Low Risk for Bacteremia
    Cost, Carrye R.
    Stegner, Martha M.
    Leonard, David
    Leavey, Patrick
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (03) : 206 - 211
12345